DENTSPLY SIRONA (NASDAQ:XRAY) Stock Unloaded Rep. Gilbert Ray Cisneros, Jr.

Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY). In a filing disclosed on February 11th, the Representative disclosed that they had sold between $1,001 and $15,000 in DENTSPLY SIRONA stock on January 8th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of ICF International (NASDAQ:ICFI) on 2/3/2025.
• Purchased $15,001 – $50,000 in shares of CACI International (NYSE:CACI) on 1/31/2025.
• Purchased $50,001 – $100,000 in shares of Hawaiian Electric Industries (NYSE:HE) on 1/31/2025.
• Sold $1,001 – $15,000 in shares of Broadcom (NASDAQ:AVGO) on 1/30/2025.
• Purchased $1,001 – $15,000 in shares of Intuitive Surgical (NASDAQ:ISRG) on 1/30/2025.
• Purchased $1,001 – $15,000 in shares of Agios Pharmaceuticals (NASDAQ:AGIO) on 1/29/2025.
• Purchased $1,001 – $15,000 in shares of SpringWorks Therapeutics (NASDAQ:SWTX) on 1/29/2025.
• Purchased $1,001 – $15,000 in shares of Paragon 28 (NYSE:FNA) on 1/29/2025.
• Purchased $1,001 – $15,000 in shares of U.S. Physical Therapy (NYSE:USPH) on 1/29/2025.
• Purchased $1,001 – $15,000 in shares of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 1/29/2025.

DENTSPLY SIRONA Trading Up 2.2 %

Shares of NASDAQ:XRAY traded up $0.40 during trading on Thursday, reaching $18.77. The company’s stock had a trading volume of 2,129,084 shares, compared to its average volume of 2,337,103. The stock has a market capitalization of $3.73 billion, a PE ratio of -9.07, a price-to-earnings-growth ratio of 1.83 and a beta of 0.96. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The firm’s 50 day simple moving average is $19.04 and its two-hundred day simple moving average is $22.04. DENTSPLY SIRONA Inc. has a 12 month low of $17.21 and a 12 month high of $34.91.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, January 10th. Stockholders of record on Friday, December 27th were issued a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 3.41%. The ex-dividend date of this dividend was Friday, December 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -30.92%.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on XRAY. Morgan Stanley lowered their price target on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a report on Tuesday, December 17th. Needham & Company LLC reaffirmed a “buy” rating and set a $25.00 price objective on shares of DENTSPLY SIRONA in a research report on Tuesday. Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and decreased their price target for the company from $30.00 to $20.00 in a research report on Thursday, January 23rd. Barrington Research cut their price objective on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research report on Friday, November 8th. Finally, StockNews.com raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, February 7th. Nine research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, DENTSPLY SIRONA currently has an average rating of “Hold” and an average price target of $26.33.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Creative Planning increased its holdings in DENTSPLY SIRONA by 53.9% during the 2nd quarter. Creative Planning now owns 16,540 shares of the medical instruments supplier’s stock worth $412,000 after purchasing an additional 5,793 shares during the period. Sanctuary Advisors LLC acquired a new position in DENTSPLY SIRONA in the 2nd quarter valued at $481,000. GAMMA Investing LLC grew its holdings in DENTSPLY SIRONA by 133.4% during the third quarter. GAMMA Investing LLC now owns 2,488 shares of the medical instruments supplier’s stock worth $67,000 after acquiring an additional 1,422 shares during the period. CWM LLC grew its position in DENTSPLY SIRONA by 118.2% during the third quarter. CWM LLC now owns 7,337 shares of the medical instruments supplier’s stock worth $199,000 after buying an additional 3,975 shares during the period. Finally, UMB Bank n.a. grew its holdings in DENTSPLY SIRONA by 430.3% in the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after purchasing an additional 753 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.